The genomics and therapeutics of HER2-positive gastric cancer—from trastuzumab and beyond

Por Kelly, Ciara M., Janjigian, Yelena Y.
Publicado no J Gastrointest Oncol (2016)

Molecular Classification of Gastric Cancer: A new paradigm

Por Shah, Manish A., Khanin, Raya, Tang, Laura, Janjigian, Yelena Y., Klimstra, David S., Gerdes, Hans, Kelsen, David P.
Publicado em 2011

Prognostic significance of PET assessment of metabolic response to therapy in oesophageal squamous cell carcinoma

Por Chhabra, Arpit, Ong, Leonard T, Kuk, Deborah, Ku, Geoffrey, Ilson, David, Janjigian, Yelena Y, Wu, Abraham, Schöder, Heiko, Goodman, Karyn A
Publicado no Br J Cancer (2015)

Pack Years of Cigarette Smoking as a Prognostic Factor in Patients with Stage IIIB/IV Non-Small Cell Lung Cancer

Por Janjigian, Yelena Y., McDonnell, Kevin, Kris, Mark G., Shen, Ronglai, Sima, Camelia S., Bach, Peter B., Rizvi, Naiyer A., Riely, Gregory J.
Publicado em 2010

CD44 expression denotes a subpopulation of gastric cancer cells in which Hedgehog signaling promotes chemotherapy resistance

Por Yoon, Changhwan, Park, Do Joong, Schmidt, Benjamin, Thomas, Nicholas J., Lee, Hae-June, Kim, Teresa S., Janjigian, Yelena Y., Cohen, Deirdre J., Yoon, Sam S.
Publicado em 2014

Risk factors for Recurrence in T1-2N0 Gastric Cancer in the United States and China

Por Cao, Liang, Selby, Luke V., Hu, Xiang, Zhang, Yi, Janjigian, Yelena Y., Tang, Laura, Coit, Daniel G., Brennan, Murray F., Strong, Vivian E.
Publicado no J Surg Oncol (2016)

MET expression and amplification in patients with localized gastric cancer

Por Janjigian, Yelena Y., Tang, Laura H., Coit, Daniel G., Kelsen, David P., Francone, Todd D., Weiser, Martin R., Jhanwar, Suresh C., Shah, Manish A.
Publicado em 2011

Morbidity after Total Gastrectomy: Analysis of 238 Patients

Por Selby, Luke V., Vertosick, Emily A., Sjoberg, Daniel D., Schattner, Mark A., Janjigian, Yelena Y., Brennan, Murray F., Coit, Daniel G., Strong, Vivian E.
Publicado no J Am Coll Surg (2015)

A Phase I Trial of SJG-136 (NSC#694501) in Advanced Solid Tumors

Por Janjigian, Yelena Y, Lee, Wooin, Kris, Mark G, Miller, Vincent A, Krug, Lee M, Azzoli, Christopher G, Senturk, Emir, Calcutt, M.Wade, Rizvi, Naiyer A
Publicado em 2009

Impact on disease-free survival of adjuvant erlotinib or gefitinib in patients with resected lung adenocarcinomas that harbor epidermal growth factor receptor (EGFR) mutations

Por Janjigian, Yelena Y., Park, Bernard J., Zakowski, Maureen F., Ladanyi, Marc, Pao, William, D’Angelo, Sandra P., Kris, Mark G., Shen, Ronglai, Zheng, Junting, Azzoli, Christopher G.
Publicado em 2011

Efficacy and Safety of Bevacizumab in Active Brain Metastases from Non-Small Cell Lung Cancer

Por De Braganca, Kevin C., Janjigian, Yelena Y., Azzoli, Christopher G., Kris, Mark G., Pietanza, Maria C., Nolan, Craig P., Omuro, Antonio M., Holodny, Andrei I., Lassman, Andrew B.
Publicado em 2010

Phase II Trial of Sorafenib in Patients with Chemotherapy Refractory Metastatic Esophageal and Gastroesophageal (GE) Junction Cancer

Por Janjigian, Yelena Y., Vakiani, Efsevia, Ku, Geoffrey Y., Herrera, Jessica M., Tang, Laura H., Bouvier, Nancy, Viale, Agnès, Socci, Nicholas D., Capanu, Marinela, Berger, Michael, Ilson, David H.
Publicado no PLoS One (2015)

Monitoring Afatinib Treatment in HER2-Positive Gastric Cancer with (18)F-FDG and (89)Zr-Trastuzumab PET

Por Janjigian, Yelena Y., Viola-Villegas, Nerissa, Holland, Jason P., Divilov, Vadim, Carlin, Sean D., Gomes-DaGama, Erica M., Chiosis, Gabriela, Carbonetti, Gregory, de Stanchina, Elisa, Lewis, Jason S.
Publicado no J Nucl Med (2013)

PKLR promotes colorectal cancer liver colonization through induction of glutathione synthesis

Por Nguyen, Alexander, Loo, Jia Min, Mital, Rohit, Weinberg, Ethan M., Man, Fung Ying, Zeng, Zhaoshi, Paty, Philip B., Saltz, Leonard, Janjigian, Yelena Y., de Stanchina, Elisa, Tavazoie, Sohail F.
Publicado no J Clin Invest (2016)

Changing chemotherapy during concurrent radiation followed by surgery after sub-optimal FDG-PET response to induction chemotherapy improves outcomes in locally advanced esophageal...

Por Ku, Geoffrey Y., Kriplani, Anuja, Janjigian, Yelena Y., Kelsen, David P., Rusch, Valerie W., Bains, Manjit, Chou, Joanne, Capanu, Marinela, Wu, Abraham J., Goodman, Karyn. A, Ilson, David H.
Publicado no Cancer (2016)

Phase II study of bevacizumab and preoperative chemoradiation for esophageal adenocarcinoma

Por Ku, Geoffrey Y., Bains, Manjit S., Park, Do Joong, Janjigian, Yelena Y., Rusch, Valerie W., Rizk, Nabil P., Yoon, Sam S., Millang, Brittanie, Capanu, Marinela, Goodman, Karyn A., Ilson, David H.
Publicado no J Gastrointest Oncol (2016)

Maintained sensitivity to EGFR tyrosine kinase inhibitors in EGFR-mutant lung cancer recurring after adjuvant erlotinib or gefitinib

Por Oxnard, Geoffrey R., Janjigian, Yelena Y., Arcila, Maria E., Sima, Camelia S., Kass, Samantha L., Riely, Gregory J., Pao, William, Kris, Mark G., Ladanyi, Marc, Azzoli, Christopher G., Miller, Vincent A.
Publicado em 2011

Heat shock protein 90 inhibitors in the treatment of cancer: current status and future directions

Por Jhaveri, Komal, Ochiana, Stefan O, Dunphy, Mark PS, Gerecitano, John F, Corben, Adriana D, Peter, Radu I, Janjigian, Yelena Y, Gomes-DaGama, Erica M, Koren, John, Modi, Shanu, Chiosis, Gabriela
Publicado em 2014

Dual Inhibition of EGFR with Afatinib and Cetuximab in Kinase Inhibitor-Resistant EGFR-Mutant Lung Cancer With and Without T790M Mutations

Por Janjigian, Yelena Y., Smit, Egbert F., Groen, Harry J.M., Horn, Leora, Gettinger, Scott, Camidge, D. Ross, Riely, Gregory J., Wang, Bushi, Fu, Yali, Chand, Vikram K, Miller, Vincent A., Pao, William
Publicado em 2014

Next-Generation Assessment of Human Epithelial Growth Factor Receptor 2 (ERBB2) Amplification Status: Clinical Validation in the Context of a Hybrid Capture-Based, Comprehensive So...

Por Ross, Dara S., Zehir, Ahmet, Cheng, Donavan T., Benayed, Ryma, Nafa, Khedoudja, Hechtman, Jaclyn F., Janjigian, Yelena Y., Weigelt, Britta, Razavi, Pedram, Hyman, David M., Baselga, José, Berger, Michael F., Ladanyi, Marc, Arcila, Maria E.
Publicado no J Mol Diagn (2017)